509 related articles for article (PubMed ID: 30294255)
1. Pluripotent Stem Cell-Based Approaches to Explore and Treat Optic Neuropathies.
Rabesandratana O; Goureau O; Orieux G
Front Neurosci; 2018; 12():651. PubMed ID: 30294255
[TBL] [Abstract][Full Text] [Related]
2. Methods of Retinal Ganglion Cell Differentiation From Pluripotent Stem Cells.
Gill KP; Hewitt AW; Davidson KC; Pébay A; Wong RC
Transl Vis Sci Technol; 2014 May; 3(4):7. PubMed ID: 25774327
[TBL] [Abstract][Full Text] [Related]
3. Generation of a Transplantable Population of Human iPSC-Derived Retinal Ganglion Cells.
Rabesandratana O; Chaffiol A; Mialot A; Slembrouck-Brec A; Joffrois C; Nanteau C; Rodrigues A; Gagliardi G; Reichman S; Sahel JA; Chédotal A; Duebel J; Goureau O; Orieux G
Front Cell Dev Biol; 2020; 8():585675. PubMed ID: 33195235
[TBL] [Abstract][Full Text] [Related]
4. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
[TBL] [Abstract][Full Text] [Related]
5. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
6. Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium.
Soucy JR; Aguzzi EA; Cho J; Gilhooley MJ; Keuthan C; Luo Z; Monavarfeshani A; Saleem MA; Wang XW; Wohlschlegel J; ; Baranov P; Di Polo A; Fortune B; Gokoffski KK; Goldberg JL; Guido W; Kolodkin AL; Mason CA; Ou Y; Reh TA; Ross AG; Samuels BC; Welsbie D; Zack DJ; Johnson TV
Mol Neurodegener; 2023 Sep; 18(1):64. PubMed ID: 37735444
[TBL] [Abstract][Full Text] [Related]
7. Advances in the Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells.
Ohlemacher SK; Langer KB; Fligor CM; Feder EM; Edler MC; Meyer JS
Adv Exp Med Biol; 2019; 1186():121-140. PubMed ID: 31654388
[TBL] [Abstract][Full Text] [Related]
8. Hereditary Optic Neuropathies: A Systematic Review on the Interplay between Biomaterials and Induced Pluripotent Stem Cells.
Ladero M; Reche-Sainz JA; Gallardo ME
Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247929
[TBL] [Abstract][Full Text] [Related]
9. Cell replacement with stem cell-derived retinal ganglion cells from different protocols.
Luo Z; Chang KC
Neural Regen Res; 2024 Apr; 19(4):807-810. PubMed ID: 37843215
[TBL] [Abstract][Full Text] [Related]
10. The use of induced pluripotent stem cells for studying and treating optic neuropathies.
Khan S; Hung SS; Wong RC
Curr Opin Organ Transplant; 2016 Oct; 21(5):484-9. PubMed ID: 27517502
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of retinal ganglion cells from induced pluripotent stem cells: a review.
Ji SL; Tang SB
Int J Ophthalmol; 2019; 12(1):152-160. PubMed ID: 30662854
[TBL] [Abstract][Full Text] [Related]
12. Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration.
Ohlemacher SK; Sridhar A; Xiao Y; Hochstetler AE; Sarfarazi M; Cummins TR; Meyer JS
Stem Cells; 2016 Jun; 34(6):1553-62. PubMed ID: 26996528
[TBL] [Abstract][Full Text] [Related]
13. The Potential and Application of iPSCs in Gene and Cell Therapy for Retinopathies and Optic Neuropathies.
Lapshin EV; Gershovich YG; Karabelsky AV
Acta Naturae; 2023; 15(4):56-64. PubMed ID: 38234607
[TBL] [Abstract][Full Text] [Related]
14. Human Periodontal Ligament-Derived Stem Cells Promote Retinal Ganglion Cell Survival and Axon Regeneration After Optic Nerve Injury.
Cen LP; Ng TK; Liang JJ; Zhuang X; Yao X; Yam GH; Chen H; Cheung HS; Zhang M; Pang CP
Stem Cells; 2018 Jun; 36(6):844-855. PubMed ID: 29476565
[TBL] [Abstract][Full Text] [Related]
15. Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy.
Parameswaran S; Dravid SM; Teotia P; Krishnamoorthy RR; Qiu F; Toris C; Morrison J; Ahmad I
Stem Cells; 2015 Jun; 33(6):1743-58. PubMed ID: 25753398
[TBL] [Abstract][Full Text] [Related]
16. Hereditary Optic Neuropathies: Induced Pluripotent Stem Cell-Based 2D/3D Approaches.
García-López M; Arenas J; Gallardo ME
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33477675
[TBL] [Abstract][Full Text] [Related]
17. Polybenzyl Glutamate Biocompatible Scaffold Promotes the Efficiency of Retinal Differentiation toward Retinal Ganglion Cell Lineage from Human-Induced Pluripotent Stem Cells.
Chen TC; She PY; Chen DF; Lu JH; Yang CH; Huang DS; Chen PY; Lu CY; Cho KS; Chen HF; Su WF
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621308
[TBL] [Abstract][Full Text] [Related]
18. Organoid technology for retinal repair.
Llonch S; Carido M; Ader M
Dev Biol; 2018 Jan; 433(2):132-143. PubMed ID: 29291970
[TBL] [Abstract][Full Text] [Related]
19. Towards stem cell-based neuronal regeneration for glaucoma.
Hua ZQ; Liu H; Wang N; Jin ZB
Prog Brain Res; 2020; 257():99-118. PubMed ID: 32988476
[TBL] [Abstract][Full Text] [Related]
20. Glaucoma and optic nerve repair.
Diekmann H; Fischer D
Cell Tissue Res; 2013 Aug; 353(2):327-37. PubMed ID: 23512141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
